483 Teva Czech Industries s.r.o. Mar 2017

483 Teva Czech Industries s.r.o. Mar 2017

Laurimer Kuilan-Torres FDA, Christina Miller FDA$119.00 - Available Now

FDA investigators audited the Teva Czech Industries s.r.o. - Opava 9, Czech Republic facility and issued inspectional observations (via FDA 483) on 24 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Mar 2017
  • Location: Opava 9, Czech Republic
  • FEI: 1000282452
Add To Cart